Supervisory Board

The Supervisory Board supervises the policies of the executive management and the general course of affairs of Koninklijke Philips N.V. and advises the executive management thereon. The Supervisory Board, in the two-tier corporate structure under Dutch law, is a separate and independent corporate body.

The Rules of Procedure of the Supervisory Board are published on the Company’s website. For details on the activities of the Supervisory Board, see Supervisory Board report and Supervisory Board.

  • Jeroen van der Veer

    Jeroen van der Veer

    1947, Dutch** ***

    Chairman
    Chairman of Corporate Governance and Nomination & Selection Committee
    Member of the Supervisory Board since 2009; second term expires in 2017
    Former Chief Executive of Royal Dutch Shell and Chairman of the Supervisory Board of ING Group. Member of the Supervisory Board of Concertgebouw N.V.
  • James Schiro

    James Schiro

    1946, American** ***

    Vice-Chairman and Secretary; Chairman of the Remuneration Committee
    Member of the Supervisory Board since 2005; third term expires in 2017
    Former CEO of Zurich Financial Services and Chairman of the Group Management Board. Also serves on various boards of private and listed companies including Goldman Sachs as Lead Director and member of the audit committee, PepsiCo as member of the Supervisory Board and Reva Medical as member of the Supervisory Board. Senior Advisor CVC Capital Partners Ltd.
  • Kees van Lede

    Kees van Lede

    1942, Dutch*

    Member of the Supervisory Board since 2003; third term expires in 2015
    Former Chairman of the Board of Management of Akzo Nobel and currently Chairman of the Supervisory Board of Royal Imtech N.V. Member of the Supervisory Boards of AirFrance/KLM, Air Liquide and Senior Advisor JP Morgan Plc.
  • Ewald Kist

    Ewald Kist

    1944, Dutch**

    Member of the Supervisory Board since 2004; third term expires in 2016
    Former Chairman of the Executive Board of ING Group and currently member of the Supervisory Boards of DSM, Moody’s Investor Service and Stage Entertainment
  • Heino von Prondzynski

    Heino von Prondzynski

    1949, German*

    Member of the Supervisory Board since 2007; second term expires in 2015
    Former member of the Corporate Executive Committee of the F. Hofmann-La Roche Group and former CEO of Roche Diagnostics, currently Chairman of the Supervisory Board of HTL Strefa and Epigenomics AG. Member of the Supervisory Board of Hospira
  • Christine Poon

    Christine Poon

    1952, American** ***

    Member of the Supervisory Board since 2009; second term expires in 2017
    Former Vice-Chairman of Johnson & Johnson’s Board of Directors and Worldwide Chairman of the Pharmaceuticals Group. Currently dean of Ohio State University’s Fisher College of Business and member of the Board of Directors of Prudential and Regeneron
  • Jackson Tai

    Jackson Tai

    1950, American*

    Chairman of Audit Committee
    Member of the Supervisory Board since 2011; first term expires in 2015
    Former Vice-Chairman and CEO of DBS Group and DBS Bank Ltd and former Managing Director at J.P. Morgan &Co. Incorporated. Currently a member of the Supervisory Boards of The Bank of China Limited, Singapore Airlines, MasterCard Incorporated and Eli Lilly and Company. Also Non-Executive Director of privately-held Russell Reynolds Associates and of Vapor Stream
  • Neelam Dhawan

    Neelam Dhawan

    1959, Indian*

    Member of the Supervisory Board since 2012; first term expires in 2016
    Currently Managing Director of Hewlett-Packard India
*member of the Audit Committee
**member of the Remuneration Committee
***member of the Corporate Governance and Nomination & Selection Committee
(0)
(0)
This is an interactive electronic version of the Philips Annual Report 2013 and also contains certain information in summarized form. The contents of this version are qualified in their entirety by reference to the printed version of the full Philips Annual Report 2013. This printed version is available as a PDF file on this website. Information about: forward-looking statements, third-party market share data, fair value information, IFRS basis of presentation, use of non-GAAP information, statutory financial statements and management report, reclassifications and analysis of 2013 compared to 2012.